<!– –> <!– Page Last Updated: 02/09/2012 –> Page Last Updated: 02/09/2012 <!– –> Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
FDA Drug Safety Communication: Important drug interactions between Victrelis (boceprevir) and ritonavir-boosted human immunodeficiency virus (HIV) protease inhibitor drugs
<!– –> <!– Page Last Updated: 02/08/2012 –> Page Last Updated: 02/08/2012 <!– –> Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Meeting Materials for the Neurological Devices Panel meeting to be held on 2/10/12
<!– –> <!– Page Last Updated: 02/08/2012 –> Page Last Updated: 02/08/2012 <!– –> Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Proton Pump Inhibitors (PPIs) – Drug Safety Communication: Clostridium Difficile
<!– –> <!– Page Last Updated: 02/08/2012 –> Page Last Updated: 02/08/2012 <!– –> Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Prescription to Over-the-Counter (OTC) Switch List
<!– –> <!– Page Last Updated: 02/08/2012 –> Page Last Updated: 02/08/2012 <!– –> Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
FDA Drug Safety Communication: Clostridium difficile-associated diarrhea can be associated with stomach acid drugs known as proton pump inhibitors (PPIs)
 Safety AnnouncementAdditional Information for Patients and ConsumersAdditional Information for Healthcare ProfessionalsData Summary (Tables)  Safety Announcement [02-08-2012] The U.S. Food and Drug Administration (FDA) is informing the public that the use of stomach acid drugs known as proton pump inhibitors (PPIs) may be associated with an increased risk of Clostridium difficile–associated diarrhea (CDAD). A…
Resources and Tools for Preventing Surgical Fires
<!– –> <!– Page Last Updated: 02/06/2012 –> Page Last Updated: 02/06/2012 <!– –> Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Public Workshop – Cardiovascular Metallic Implants: Corrosion, Surface Characterization, and Nickel Leaching, March 8
The Food and Drug Administration (FDA) is announcing a public workshop on Cardiovascular Metallic Implants: Corrosion, Surface Characterization, and Nickel Leaching. The purpose of this workshop is to provide a forum for FDA, cardiovascular device manufacturers, test houses, and academia to discuss corrosion, surface characterization, and nickel leach testing, as well as collect comments and…
Healthy People Co. Dietary Supplements: Recall
<!– –> <!– Page Last Updated: 02/06/2012 –> Page Last Updated: 02/06/2012 <!– –> Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Gris-PEG (griseofulvin ultramicrosize): Health Advisory – Risk of Product Mix
<!– –> <!– Page Last Updated: 02/03/2012 –> Page Last Updated: 02/03/2012 <!– –> Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.